The United States Food and Drug Administration has chosen Dr Vinay Prasad to lead its Center for Biologics Evaluation and Research.

In the wake of the high-profile departure of Peter Marks, M.D., Ph.D., the FDA has a new leader for its Center for Biologics ...

FDA commissioner Marty Makary told FDA staff in an email that Prasad, “brings a great set of skills, energy, and competence ...

The independent experts will meet on May 22 to discuss updates to the COVID-19 vaccine for the upcoming season.

CBER’s new chief has argued for more stringent measures of assessing drugs for cancer and rare diseases, suggesting he might ...

Compounding pharmacies suffered another blow yesterday, as a federal judge sided with the FDA over its decision last year to ...

With a demand that vaccine boosters be tested against placebos, RFK Jr. puts an old antivaccine claim at the forefront of government health policy.

In his new role with the FDA, Dr. Vinay Prasad will oversee the regulation of costly drugs, including vaccines, gene ...

Axon named Tina Hahn as president and managing partner. Bristol Myers Squibb promoted Cari Gallman to EVP, general counsel ...

We want you to take advantage of everything Cancer Therapy Advisor has to offer. To view unlimited content, log in or register for free.

The appointment, announced May 6 by FDA Commissioner Dr. Marty Makary, places Prasad at the helm of one of the agency’s most ...